KOMPLIKASI PADA PASIEN INFARK MIOKARD AKUT ST-ELEVASI (STEMI) YANG MENDAPAT MAUPUN TIDAK MENDAPAT TERAPI REPERFUSI :(Studi di RSUP Dr.Kariadi Semarang)

Abstract

Background: STEMI, a medical emergency with high morbidity and mortality of complications, requires right and immediate treatment. Reperfusion therapy (fibrinolytic and PCI) given at right indication and time (<12 hours), may reduce the incidence of complications. Incidence of STEMI and its complications in the Kariadi hospital are quite a lot, but there has been no research on this in Kariadi hospital. The objective of this study is to describe complications in STEMI patients received and did not receive reperfusion therapy. Methods: This study is descriptive study in the subject of STEMI patients that came to Kariadi hospital from January to December 2011. Data was obtained from medical records of STEMI patients, both received and didn’t receive reperfusion therapy. Results: There were 105 cases of STEMI consisting of 20% patients received reperfusion therapy and 80% patients did not receive reperfusion therapy. Frequent complications in patients received reperfusion therapy are minor bleeding (19.1%), heart failure (14.3%), and death (9.5%), while in patients who didn’t receive reperfusion therapy are heart failure (25%), cardiac arrest (16,7%), and death (15.5%). Conclusion: Most of the STEMI patients in Kariadi hospital did not receive reperfusion therapy because time window between onset of chest pain until arriving at the hospital is more than 12 hours. Heart failure, cardiac arrest, and death were more often in patients who didn’t receive reperfusion therapy, while minor bleeding was more often in patients receiving reperfusion therapy. Keywords: STEMI, reperfusion therapy, complication.